glp 1 meds canada New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions Canada approves first generic version

Finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, is recommended at a daily dose of 20 mg for patients with eGFR 60 mL/min/1.73 m and 10 mg for those with eGFR between 25 and 60 mL/min/1.73 m

Most people find that the best results appear after 812 weeks of uninterrupted daily use

INDUSTRIE 4.0 Industrial IoT & Smart Factory transformieren Fertigungsprozesse durch intelligente Automatisierung und Echtzeitdaten

In a randomized placebo-controlled, double-blinded trial, although liraglutide did not affect A load and cognition measures, 26 weeks of liraglutide treatment prevented expected decline of glucose metabolism that signifies cognitive impairment, synaptic dysfunction, and disease evolution (243)

It neutralizes free radicals and helps to protect cells from oxidative stress, which can contribute to various chronic conditions and signs of aging

PRISMA Checklist for the Meta-analysis